Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies

OBJECTIVE: After an initially successful islet cell transplantation, a number of patients return to C-peptide negativity, and therefore immunosuppressive therapy is discontinued. Some are then found to have developed Graves disease. We examined the risk of Graves disease after immunosuppression. RES...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gillard, Pieter, Huurman, Volkert, Van der Auwera, Bart, Decallonne, Brigitte, Poppe, Kris, Roep, Bart O., Gorus, Frans, Mathieu, Chantal, Pipeleers, Daniel, Keymeulen, Bart
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Diabetes Association 2009
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2752930/
https://ncbi.nlm.nih.gov/pubmed/19549735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-2339
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi